SCHEMBL759613

SCHEMBL759613

COC(=O)C[PH](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.42
ALDH1A1 P00352 3/20 0.41
LMNA P02545 3/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
AKT1 P31749 1/20 0.40
HSD17B10 Q99714 2/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KMT2A Q03164 2/20 0.38
KCNN4 O15554 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
CA12 O43570 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL29024015 0.98 POLB (0.44) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL12231875 0.87 SMN1; SMN2 (0.41) POLBSMN1; SMN2HSD17B10NPC1HPGD
SCHEMBL23731932 0.84 POLB (0.46) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL3633415 0.83 ALDH1A1 (0.38) POLBTSHRALDH1A1LMNAAKT1
SCHEMBL17324397 0.82 POLB (0.44) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL12231896 0.82 TSHR (0.40) TSHRALDH1A1SMN1; SMN2HSD17B10CA12
SCHEMBL9524467 0.81 ALDH1A1 (0.50) POLBTSHRALDH1A1LMNAKDM4E
SCHEMBL8924942 0.81 ALDH1A1 (0.40) POLBTSHRALDH1A1KDM4EHSD17B10
SCHEMBL65904 0.81 MEN1 (0.47) TSHRALDH1A1SMN1; SMN2NPC1KMT2A
SCHEMBL1669392 0.79 CYP2C19 (0.39) TSHRALDH1A1KDM4ESMN1; SMN2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101824004-B Synthesization technique for ceftibuten side chain HUANGSHAN SHEXIAN HONGHUI CHEMICAL CO LTD 2012-02-22 CN claimed
CN-101824004-A Synthesization technique for ceftibuten side chain HUANGSHAN SHEXIAN HONGHUI CHEMICAL CO LTD 2010-09-08 CN claimed
US-6444294-B1 MULTILAYER PHOTOGRAPHIC FILMS XEROX CORPORATION 2002-09-03 US claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
US-20260118757-A1 RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-04-30 US disclosed
US-20250235805-A1 LUBRICANT FOR FILTRATION CONTAINING ONIUM IONS TOKUYAMA CORPORATION (JP) 2025-07-24 US disclosed
US-20250215574-A1 SEMICONDUCTOR TREATMENT LIQUID FOR REMOVING RUTHENIUM SILICIDE TOKUYAMA CORPORATION (JP) 2025-07-03 US disclosed
US-20250084309-A1 SEMICONDUCTOR PROCESSING SOLUTION TOKUYAMA CORPORATION (JP) 2025-03-13 US disclosed
EP-4506982-A1 LUBRICANT FOR FILTRATION CONTAINING ONIUM IONS TOKUYAMA CORPORATION (JP) 2025-02-12 EP disclosed
WO-2024242171-A1 RADIATION-SENSITIVE COMPOSITION FOR FORMING GATE INSULATING FILM, PATTERN, METHOD FOR PRODUCING PATTERN, CURED FILM FOR GATE INSULATING FILM, SEMICONDUCTOR ELEMENT, ORGANIC ELECTROCHEMICAL TRANSISTOR, ORGANIC EL DISPLAY DEVICE, LIQUID CRYSTAL DISPLAY DEVICE, MICRO-LED DISPLAY DEVICE, QUANTUM DOT LIGHT-EMITTING DISPLAY DEVICE, WEARABLE DEVICE, ELECTRONIC SKIN DEVICE, BIOLOGICAL SENSOR, AND NEUROMORPHIC DEVICE JSR株式会社 2024-11-28 WO disclosed
WO-2024143473-A1 DECOMPOSITION INHIBITOR FOR TRANSITION METAL OXIDANTS 株式会社トクヤマ 2024-07-04 WO disclosed
WO-1994015956-A1 ENDOTHELIN CONVERTING ENZYME INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1994-07-21 WO disclosed
CN-1061777-A Substituted aryl-haloalkyl-pyrazoles as herbicides MONSANTO CO (US) 1992-06-10 CN disclosed
US-5004822-A Isomers of 3-acetyl-2,2-dimethyl cyclopropane carboxylic acid derivatives NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1991-04-02 US disclosed
CN-1043125-A Be used as the aryl urea of the replacement of high-potency sweetener NUTRASWEET CO (US) 1990-06-20 CN disclosed
EP-0352230-A2 Optical palmitoylglucopyranoside isomer and process for its preparation CIBA-GEIGY AG (CH) 1990-01-24 EP disclosed
CN-1030415-A Saturated heterocycle carboxamide derivatives and its preparation method YAMANOUCHI PHARMA CO LTD (JP) 1989-01-18 CN disclosed
US-4622337-A INSECTICIDES NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-11-11 US disclosed
US-4464391-A Pesticides NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118757-A1 RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SLC39A14, HCN4, SLC11A2 POLB 876/4885TSHR 897/4885ALDH1A1 4370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.